Skip to main content

Webinar: Advancing drug safety with Natural Language Processing

When: Thursday 28th March 2019

Time: 3:00pm GMT; 4pm CET; 11:00am EDT; 8:00am PDT

Duration: 60 minutes.


Drug safety is of critical importance, at all stages in drug discovery, development and delivery. Across the whole span, safety-relevant data is being both generated and sought from unstructured text – from internal safety reports, scientific literature, individual case safety reports, clinical investigator brochures, patient forums, social media, conference abstracts.

Intelligent search across these hundreds of thousands of pages can provide the information for key decision support. Many of our customers are using the power of Linguamatics Natural Language Processing (NLP) platform to transform the unstructured text into actionable structured data that can be rapidly visualized and analysed, at every stage through the safety lifecycle of a drug. This webinar will present an overview of customer success stories, to show best practice use of this Artificial Intelligence (AI) technology to advance drug safety.

What will you learn?

  • How natural language processing (NLP) text mining can extract structured data from unstructured text in scientific papers, clinical trial databases, internal safety reports, FDA drug labels, and more.
  • How big pharma access  internal data silos and external data sources for safety decision making. Use cases include Merck for preclinical toxicology reports and Agios Pharmaceuticals for clinical safety

Who should attend?

Anyone with an interest in getting better value from their textual information, and integrating diverse data sets to provide knowledge relevant to drug safety and risk prediction.

Specifically, informaticians, information professionals, researchers, with responsibility for:

  • Risk profiles for targets in early drug discovery
  • Preclinical and clinical drug safety
  • Safety assessment across pipeline


Jane Z. Reed, Head of Life Science, Linguamatics

Jane Reed is Head of Life Science at Linguamatics. She is responsible for developing the strategic vision for Linguamatics’ growing product portfolio and business development in the life science domain. Jane has extensive experience in life science informatics. She worked for more than 15 years in vendor companies supplying data products, data integration and analysis, and consultancy to pharma and biotech—with roles at Instem, BioWisdom, Incyte, and Hexagen. Before moving into the life science industry, Jane worked in academia with post-docs in genetics and genomics.

John Haldoupis, Application Specialist, Linguamatics

John Haldoupis is an application specialist at Linguamatics. John studied computational chemistry for drug discovery for his PhD, and now works with Linguamatics customers to understand their needs and apply I2E text mining and NLP methods to transform their information into knowledge.